Evidence map›Paper›PMID 36247106›Full record

ArticleParkinson's disease2022

Parkinsonics: A Randomized, Blinded, Cross-Over Trial of Group Singing for Motor and Nonmotor Symptoms in Idiopathic Parkinson Disease.

Ankur Butala, Kevin Li, Aathman Swaminathan, Susan Dunlop, Yekaterina Salnikova, Bronte Ficek, Brandon Portnoff, Michael Harper, Bailey Vernon, Bela Turk and 2 more

Open access · goldAbstract read
In one paragraph

Article in Parkinson's disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Music Therapy and Music-Based Interventions for Movement Disorders.Current neurology and neuroscience reports · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ankur ButalaDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore MD 21218, USA.
Kevin LiKrieger School of Arts and Sciences, Johns Hopkins University, Baltimore MD, USA.ORCID https://orcid.org/0000-0002-2415-4704
Aathman SwaminathanDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore MD 21218, USA.
Susan DunlopDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore MD 21218, USA.
Yekaterina SalnikovaDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore MD 21218, USA.
Bronte FicekDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore MD 21218, USA.ORCID https://orcid.org/0000-0001-7409-1476
Brandon PortnoffDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore MD 21218, USA.
Michael HarperDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore MD 21218, USA.
Bailey VernonDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore MD 21218, USA.
Bela TurkMoser Center for Leukodystrophies, Kennedy Krieger Institute, Johns Hopkins Medical Institutions, Baltimore MD, USA.ORCID https://orcid.org/0000-0002-7107-2816
Zoltan MariDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore MD 21218, USA.ORCID https://orcid.org/0000-0003-0356-9879
Alexander PantelyatDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore MD 21218, USA.ORCID https://orcid.org/0000-0002-6427-7485
Johns Hopkins University · USKennedy Krieger Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Parkinson's disease (PD) frequently causes communication difficulties due to various voice impairments and there are few treatment options for vocal/communication complaints. We assessed the effects of weekly group singing on PD patients' objective vocal and motoric function, cognition, mood, self-efficacy, and quality of life. Methods: Thirty-two participants were randomly assigned to either a singing group or a facilitated discussion group weekly over 12 weeks. After 12 weeks, participants crossed over for an additional 12 weeks. Evaluations were performed at baseline and every six weeks for 30 weeks. Objective voice measures included volume/loudness (decibels), held vowel duration, jitter, shimmer, and harmonic-to-noise ratio. Additional outcome measures included patient-centered quality of life, voice-related quality of life, MDS-UPDRS, Montreal Cognitive Assessment, and questionnaires assessing depression, self-efficacy, and overall well-being. Results: Twenty-six participants (16 M/10F; Hoehn & Yahr stage 2.3 (range 2-3); and age 68.6 (55-89)) completed the study. Across participants in both groups (intention-to-treat analyses), there was significant improvement from baseline in average loudness on the Cookie Theft picture description at 24 weeks (end of interventions), corresponding with improved minimal reading volumes at 24 weeks and 30 weeks (end of study). Similarly, there were improvements in minimal loudness on Rainbow passage reading at 24 and 30 weeks. There were improvements observed in the Emotional Well-Being (mean delta -12.7 points, Conclusions: Weekly group singing may improve some aspects of conversational voice volume and quality of life in PD. Some improvements were sustained at least six weeks after interventions ended. Further investigations of the mechanism of benefit and randomized controlled studies (without crossover) to assess the longitudinal effects of singing in PD are necessary.

Identifiers

PMID36247106
PMCPMC9553721
OpenAlexW4297922079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.